Cite

    Matsuda, K. et al. (2020). Combined immunosuppressive therapy provides favorable prognosis and increased risk of cytomegalovirus reactivation in anti‐melanoma differentiation‐associated gene 5 antibody‐positive dermatomyositis. Journal of dermatology. 47 (5), pp. 483-489. [Online].